The only known receptor for CXCL12, CXCR4, was previously shown to be expressed in different cancers including cutaneous melanoma, colon cancer, prostate cancer, breast cancer and neuroblastoma [19]. This evidence concerns the gene CXCL12 and prostate carcinoma.